Physalin B has been reported to have a wide range of biological activities and can be used to treat diseases such as inflammatory eczema and herpes. Physalin B inhibits NF-κB and NLRP3 by activating the PI3K/Akt pathway, thereby improving the inflammatory response caused by LPS-induced acute lung injury. Physalin B inhibited PDGF-BB-induced proliferation, migration and phenotypic transformation of VSMC by activating the Nrf2 pathway. Physalin B exerts antitumor activity by inhibiting LAP2α-HDAC1-mediated glioma-associated oncogene-1 deacetylation and hepatic stellate cell activation.
- Size: 5mg
- Purity: HPLC≥95%
- Molecular Formula: C 2 8 H 3 0 O 9
- Molecular Weight: 510.53
- Physical State: Solid
- Storage: Powder:2-8℃, 2 years;Insolvent(Mother Liquid):-20℃, 6 months;-80℃, 1 year
- Brand: Saint Michael
- Catalogue No.: IPA11070-5mg
For laboratory research use only. Not for human or animal consumption, diagnostic or therapeutic use.
Write Your Own Review